查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1817410

脊椎穿刺针的全球市场::各类型，各用途，各终端用户，各地区，2027年预测

Global Spinal Needles Market Research Report Information by Type, by Application, by End User, and by Region Forecast till 2027
出版日期: | 出版商: Market Research Future | 英文 114 Pages | 订单完成后即时交付

价格

产业概要

全球脊椎穿刺针市场预计将以7.48%的复合年增长率成长，到2027年底将达到3.5674亿美元。脊椎穿刺针是一种细长空心的装置，用于穿透脊椎管进行麻醉或脑脊髓液抽取。其锋利精准的针尖确保了精细操作的精确度，同时降低了受伤风险。其常见应用包括腰椎穿刺、脊椎麻醉和某些治疗介入。

推动全球市场发展的关键因素之一是符合人体工学的脊椎关节在疼痛管理、椎体成形术、椎体后凸成形术和脊椎融合术等治疗手术中的应用日益增多。由于其卓越的安全性和有效性，外科医生越来越青睐使用铅笔尖穿刺针进行麻醉，推动了其应用的不断增加。脊椎穿刺针的设计、各种临床试验以及政府对研究的投入都在不断进步。脊椎器械的预测市场可能会受到该领域从开放性手术到微创手术的最新趋势的强烈影响。

公司主要发展

美敦力公司持续稳定地加强其在脊椎外科领域的全球影响力。尤其值得一提的是，美敦力于2020年11月收购了法国Medicrea公司，这使得美敦力能够将基于人工智慧的尖端技术应用于手术计画、植入物和机器人技术，成为首家在该领域提供此类解决方案的公司。收购专注于脊椎植入物表面技术的美国公司Titan Spine，为美敦力提供了新的技术和专业知识资源，巩固了其作为脊椎植入物领先製造商的地位。透过这些举措，美敦力彰显了对技术创新、企业扩张和脊椎相关医疗保健进步的承诺。

主要参与者

全球脊椎穿刺针市场的主要参与者包括史赛克 (Stryker)、波士顿科学公司 (Boston Scientific Corporation)、贝朗梅尔松根公司 (B. Braun Melsungen AG)、美敦力公司 (Medtronic Plc)、史密斯医疗 (Smiths Medical)、碧迪公司 (Becton, Dickinson, and

报告属性详情

  • 2020 年市场规模：2.1642 亿美元
  • 2027 年市场规模：3.5674 亿美元
  • 复合年增长率 (2021-2027)：7.48%
  • 基准年：2020 年
  • 市场预测期：2021-2027 年

按行业细分

  • 依类型：非侵入性针：7.33%，定向脊椎针：6.52%
  • 依应用：治疗 - 7.87%，诊断 - 6.61%
  • 最终使用者：医院和诊所 - 8.39%，诊断中心 - 7.54%

地区分析

美洲地区脊椎穿刺针的使用量显着增加，主要原因是退化性脊椎和神经系统疾病的发生率不断上升。美国仍然是最大的贡献者，每年新增数千例，而脊椎和脑肿瘤的发生率不断上升，促使对腰椎穿刺等诊断服务的需求增加。由于脊椎疾病发生率高且医疗器材普及，北美地区仍是最大的市场，2020 年市场规模达 6,754 万美元。拉丁美洲的市场规模为 2054 万美元，并且随着人们对脊椎诊断服务的认识和需求而不断增长。

欧洲脊椎穿刺针市场的主要驱动力是该大陆人口老化，这使得该地区患有神经退化性疾病的风险更高。根据欧盟统计局的数据，未来 65 岁及以上人口将大幅成长，这将推动对脊椎诊断和治疗的需求成长。西欧占4,253万美元，东欧占1,468万美元，展现出成熟市场和新兴市场的混合。

亚太地区的成长势头迅猛，主要得益于对先进医疗服务的巨大需求以及不断扩大的研究活动。中国和印度不断增加对医疗基础设施的投资，不仅使其成为该地区最大的市场，也提高了医疗服务的可近性。在医疗保健进步的推动下，亚太地区正在迅速扩张，其中中国占998万美元，印度占825万美元，日本占709万美元。

虽然中东和非洲的市场占有率较小，但对医疗设施投资的增加带来了越来越多的机会。基础设施的改善和医疗支出的增加正在推动中东国家对医疗服务的采用。与国际医疗器材公司的合作正在改善非洲地区脊椎穿刺针的可及性。

目录

第1章 摘要整理

第2章 市场简介

第3章 调查手法

第4章 市场动态

  • 概要
  • 促进因素
    • 脊椎狭窄和神经系统疾病盛行率不断上升
    • 老年人口日益易患脊椎疾病
    • 脊椎穿刺针在脊椎手术的使用日益增多
  • 阻碍因素
    • 脊椎手术相关的副作用和併发症
    • 严格的政府法规
  • 机遇
    • 不断增加的合作、收购和产品发布

第5章 市场要素分析

  • 价值链分析
  • 波特的五力分析
  • COVID-19影响分析

第6章 全球脊椎穿刺针市场(各类型)

  • 简介
  • 非侵入性脊椎穿刺针
  • 定向脊椎穿刺针
  • 铅笔尖穿刺针

第7章 全球脊椎穿刺针市场(各用途)

  • 简介
  • 治疗
  • 诊断

第8章 脊椎穿刺针市场(各终端用户)

  • 概要
  • 医院·诊所
  • 诊断中心
  • 调查室
  • 专门中心

第9章 全球脊椎穿刺针市场(各地区)

  • 概要
  • 南北美洲
    • 北美
    • 南美
  • 欧洲
    • 西欧
    • 东欧
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 其他
  • 中东·非洲
    • 中东
    • 非洲

第10章 竞争情形

  • 概要
  • 竞争基准
  • 全球脊椎穿刺针市场上主要成长策略
  • 全球脊椎穿刺针开发数的主要企业
  • 主要的开发分析
  • 主要的发展与成长策略
  • 财务矩阵

第11章 企业简介

  • STRYKER CORPORATION
  • BOSTON SCIENTIFIC CORPORATION
  • B. BRAUN MELSUNGEN AG
  • MEDTRONIC PLC
  • SMITHS MEDICAL
  • BECTON, DICKINSON, AND COMPANY
  • EXELINT INTERNATIONAL, CO.
  • ARGON MEDICAL
  • MYCO MEDICAL
  • COOK MEDICAL

第12章 附录

Product Code: MRFR/MED/0709-HCR

Global Spinal Needles Market Research Report Information by Type (Atraumatic Needles, Directional Spinal Needles, Pencil-point Needles), by Application (Therapeutic, Diagnostic), by End User (Hospitals & Clinics, Diagnostic Centers, Research Laboratories, Specialty Centers), and by Region (Americas, Europe, Asia Pacific, Middle East and Africa) Forecast till 2027

Industry Overview

The global spinal needles market is expected to be valued at USD 356.74 million with a CAGR of 7.48% by the end of 2027. A spinal needle is a thin, hollow device designed to puncture the spinal canal for administering anesthesia or withdrawing cerebrospinal fluid. Its sharp, precise tip ensures accuracy during delicate procedures while reducing the risk of injury. Common uses include lumbar punctures, spinal anesthesia, and certain therapeutic interventions.

One of the main factors for this worldwide market development is the growth in ergonomic use of the spinal joints in therapeutic procedures, such as pain management, vertebroplasty, kyphoplasty, and spinal fusion. Surgeons increasingly favor pencil-point needles for anesthesia due to superior safety and effectiveness, driving higher adoption. There is constant progress in spinal needle design, various clinical trials, and the government, which is stepping up research investments. The predicted market for spinal directing devices is going to be strongly affected by this recent development of the sector, from open surgeries to minimally invasive surgeries.

Major Company Development

Medtronic plc is still working steadily to strengthen its presence worldwide in spinal surgery through its achievements. Among others, by acquiring Medicrea in France in November 2020, Medtronic has allowed itself to adopt cutting-edge AI-driven technologies for surgical planning, as well as implants and robotics, making it the first company to launch such solutions in the sector. The takeover of Titan Spine, an American company specializing in spinal implant surface technologies, gave the company new resources for technology and expertise and strengthened its position as the leading spinal implant manufacturer. Through these movements, Medtronic sends a message of its focus on technological innovation, company expansion, and the upgrading of healthcare related to the spine.

Key Players

Major players in the global spinal needles market are Stryker, Boston Scientific Corporation, B. Braun Melsungen AG, Medtronic Plc, Smiths Medical, Becton, Dickinson, and Company, EXELINT International, Co., Argon Medical, Myco Medical, and Cook Medical.

Report Attribute Details

  • Market Size 2020: USD 216.42 Million
  • Market Size 2027: USD 356.74 Million
  • CAGR (2021-2027): 7.48%
  • Base Year: 2020
  • Market Forecast Period: 2021-2027

Industry Segmentations

  • By Type: Atraumatic Needles - 7.33%, Directional Spinal Needles - 6.52%.
  • By Application: Therapeutic - 7.87%, Diagnostic - 6.61%.
  • By End User: Hospitals & Clinics - 8.39%, Diagnostic Centers - 7.54%.

Regional Analysis

The adoption of spinal needles in the Americas is going up significantly, and the main factor for this trend is the increasing incidence of degenerative spinal and neurological diseases. The U.S. is still the biggest contributor, with the occurrence of spinal and brain cancers every year that lead to the necessity of diagnostic services like lumbar punctures, in which thousands of new cases are registered annually. Valued at USD 67.54 million in 2020, North America remains the largest market due to high incidences of spinal disorders and the broad availability of medical devices. The market in Latin America, worth USD 20.54 million, is growing as awareness and demand for spinal diagnostic services increase.

The spinal needles market in Europe is mainly supported by the continent's aging population, which has a higher risk of neurodegenerative diseases. According to Eurostat, the demographic of people aged 65 and above is going to increase drastically, and this is going to be translated into a greater need for spinal diagnostics and treatments. Western Europe generated USD 42.53 million, while Eastern Europe contributed USD 14.68 million, underscoring a mix of mature markets and emerging opportunities.

The growth of Asia-Pacific is absolutely incomparable, and the main reasons for this are the huge demand for sophisticated healthcare services and the broadened research activities. Rising investments in healthcare infrastructure in both China and India not only fuel the two countries to become the region's largest markets but also elevate accessibility. With China at USD 9.98 million, India at USD 8.25 million, and Japan at USD 7.09 million, APAC is seeing rapid uptake fueled by healthcare advancements.

Middle East & Africa hold a smaller market share, opportunities are growing with increased investments in healthcare facilities. Countries in the Middle East are witnessing rising adoption due to improving infrastructure and greater healthcare expenditure. In Africa, partnerships with international medical device companies have improved access to spinal needles.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

  • 2.1 SCOPE OF THE STUDY
  • 2.2 RESEARCH OBJECTIVE
  • 2.3 MARKET STRUCTURE
  • 2.4 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

  • 3.1 DATA MINING
  • 3.2 SECONDARY RESEARCH
  • 3.3 PRIMARY RESEARCH
  • 3.4 BREAKDOWN OF PRIMARY RESPONDENTS
  • 3.5 FORECASTING TECHNIQUES
  • 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
    • 3.6.1 BOTTOM-UP APPROACH
    • 3.6.2 TOP-DOWN APPROACH
  • 3.7 DATA TRIANGULATION
  • 3.8 VALIDATION

4 MARKET DYNAMICS

  • 4.1 OVERVIEW
  • 4.2 DRIVERS
    • 4.2.1 INCREASING PREVALENCE OF SPINAL STENOSIS AND NEUROLOGICAL DISORDERS
    • 4.2.2 RISING GERIATRIC POPULATION PRONE TO SPINAL DISORDERS
    • 4.2.3 INCREASING APPLICATION OF SPINAL NEEDLES FOR SPINE SURGERIES
  • 4.3 RESTRAINTS
    • 4.3.1 SIDE EFFECTS AND COMPLICATIONS ASSOCIATED WITH SPINE SURGERY
    • 4.3.2 STRINGENT GOVERNMENT REGULATIONS
  • 4.4 OPPORTUNITIES
    • 4.4.1 INCREASING NUMBER OF COLLABORATIONS, ACQUISITIONS, AND PRODUCT LAUNCHES

5 MARKET FACTOR ANALYSIS

  • 5.1 VALUE CHAIN ANALYSIS
    • 5.1.1 R&D AND DESIGNING
    • 5.1.2 MANUFACTURING
    • 5.1.3 DISTRIBUTION, MARKETING, & SALES
    • 5.1.4 POST-SALES MONITORING
  • 5.2 PORTER'S FIVE FORCES MODEL
    • 5.2.1 THREAT OF NEW ENTRANTS
    • 5.2.2 BARGAINING POWER OF SUPPLIERS
    • 5.2.3 THREAT OF SUBSTITUTES
    • 5.2.4 BARGAINING POWER OF BUYERS
    • 5.2.5 INTENSITY OF RIVALRY
  • 5.3 COVID-19 IMPACT ANALYSIS
    • 5.3.1 IMPACT ON SPINAL SURGERY
    • 5.3.2 IMPACT ON SPINE SURGEONS
    • 5.3.3 IMPACT ON CLINICAL TRIALS

6 GLOAL SPINAL NEEDLES MARKET, BY TYPE

  • 6.1 INTRODUCTION
  • 6.2 ATRAUMATIC NEEDLES
  • 6.3 DIRECTIONAL SPINAL NEEDLES
  • 6.4 PENCIL-POINT NEEDLES

7 GLOBAL SPINAL NEEDLES MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
  • 7.2 THERAPEUTIC
  • 7.3 DIAGNOSTIC

8 SPINAL NEEDLES MARKET, BY END USER

  • 8.1 OVERVIEW
  • 8.2 HOSPITALS & CLINICS
  • 8.3 DIAGNOSTIC CENTERS
  • 8.4 RESEARCH LABORATORIES
  • 8.5 SPECIALTY CENTERS

9 GLOBAL SPINAL NEEDLES MARKET, BY REGION

  • 9.1 OVERVIEW
  • 9.2 AMERICAS
    • 9.2.1 NORTH AMERICA
      • 9.2.1.1 US
      • 9.2.1.2 CANADA
    • 9.2.2 LATIN AMERICA
  • 9.3 EUROPE
    • 9.3.1 WESTERN EUROPE
      • 9.3.1.1 GERMANY
      • 9.3.1.2 FRANCE
      • 9.3.1.3 UK
      • 9.3.1.4 ITALY
      • 9.3.1.5 SPAIN
      • 9.3.1.6 REST OF WESTERN EUROPE
    • 9.3.2 EASTERN EUROPE
  • 9.4 ASIA PACIFIC
    • 9.4.1 CHINA
    • 9.4.2 INDIA
    • 9.4.3 JAPAN
    • 9.4.4 SOUTH KOREA
    • 9.4.5 AUSTRALIA
    • 9.4.6 REST OF ASIA PACIFIC
  • 9.5 MIDDLE EAST & AFRICA
    • 9.5.1 MIDDLE EAST
    • 9.5.2 AFRICA

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 COMPETITIVE BENCHMARKING
  • 10.3 MAJOR GROWTH STRATEGY IN THE GLOBAL SPINAL NEEDLES MARKET
  • 10.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL SPINAL NEEDLES

MARKET 80

  • 10.5 KEY DEVELOPMENT ANALYSIS
  • 10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 10.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL
    • 10.6.2 MERGER/ACQUISITION
    • 10.6.3 EXPANSION/INVESTMENT
  • 10.7 FINANCIAL MATRIX
    • 10.7.1 SALES (USD MILLION) AND OPERATING PROFIT MARGIN (%), 2020
    • 10.7.2 R&D EXPENDITURE (USD MILLION), 2020

11 COMPANY PROFILES

  • 11.1 STRYKER CORPORATION
    • 11.1.1 COMPANY OVERVIEW
    • 11.1.2 FINANCIAL OVERVIEW
    • 11.1.3 PRODUCTS OFFERED
    • 11.1.4 KEY DEVELOPMENTS
    • 11.1.5 SWOT ANALYSIS
    • 11.1.6 KEY STRATEGIES
  • 11.2 BOSTON SCIENTIFIC CORPORATION
    • 11.2.1 COMPANY OVERVIEW
    • 11.2.2 FINANCIAL OVERVIEW
    • 11.2.3 PRODUCTS/SERVICES OFFERED
    • 11.2.4 KEY DEVELOPMENTS
    • 11.2.5 SWOT ANALYSIS
    • 11.2.6 KEY STRATEGIES
  • 11.3 B. BRAUN MELSUNGEN AG
    • 11.3.1 COMPANY OVERVIEW
    • 11.3.2 FINANCIAL OVERVIEW
    • 11.3.3 PRODUCTS/SERVICES OFFERED
    • 11.3.4 KEY DEVELOPMENTS
    • 11.3.5 SWOT ANALYSIS
    • 11.3.6 KEY STRATEGIES
  • 11.4 MEDTRONIC PLC
    • 11.4.1 COMPANY OVERVIEW
    • 11.4.2 FINANCIAL OVERVIEW
    • 11.4.3 PRODUCTS/SERVICES OFFERED
    • 11.4.4 KEY DEVELOPMENTS
    • 11.4.5 SWOT ANALYSIS
    • 11.4.6 KEY STRATEGIES
  • 11.5 SMITHS MEDICAL
    • 11.5.1 COMPANY OVERVIEW
    • 11.5.2 FINANCIAL OVERVIEW
    • 11.5.3 PRODUCTS/SERVICES OFFERED
    • 11.5.4 KEY DEVELOPMENTS
    • 11.5.5 SWOT ANALYSIS
    • 11.5.6 KEY STRATEGIES
  • 11.6 BECTON, DICKINSON, AND COMPANY
    • 11.6.1 COMPANY OVERVIEW
    • 11.6.2 FINANCIAL OVERVIEW
    • 11.6.3 PRODUCTS OFFERED
    • 11.6.4 KEY DEVELOPMENTS
    • 11.6.5 SWOT ANALYSIS
    • 11.6.6 KEY STRATEGIES
  • 11.7 EXELINT INTERNATIONAL, CO.
    • 11.7.1 COMPANY OVERVIEW
    • 11.7.2 FINANCIAL OVERVIEW
    • 11.7.3 PRODUCTS OFFERED
    • 11.7.4 KEY DEVELOPMENTS
    • 11.7.5 SWOT ANALYSIS
    • 11.7.6 KEY STRATEGIES
  • 11.8 ARGON MEDICAL
    • 11.8.1 COMPANY OVERVIEW
    • 11.8.2 FINANCIAL OVERVIEW
    • 11.8.3 PRODUCTS OFFERED
    • 11.8.4 KEY DEVELOPMENTS
    • 11.8.5 SWOT ANALYSIS
    • 11.8.6 KEY STRATEGIES
  • 11.9 MYCO MEDICAL
    • 11.9.1 COMPANY OVERVIEW
    • 11.9.2 FINANCIAL OVERVIEW
    • 11.9.3 PRODUCTS OFFERED
    • 11.9.4 KEY DEVELOPMENTS
    • 11.9.5 SWOT ANALYSIS
    • 11.9.6 KEY STRATEGIES
  • 11.10 COOK MEDICAL
    • 11.10.1 COMPANY OVERVIEW
    • 11.10.2 FINANCIAL OVERVIEW
    • 11.10.3 PRODUCTS OFFERED
    • 11.10.4 KEY DEVELOPMENTS
    • 11.10.5 SWOT ANALYSIS
    • 11.10.6 KEY STRATEGIES

12 APPENDIX

  • 12.1 REFERENCES
  • 12.2 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
  • TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
  • TABLE 3 GLOBAL: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 4 GLOBAL: SPINAL NEEDLES MARKET, FOR ATRAUMATIC NEEDLES, BY REGIONS, 2018-2027 (USD MILLION)
  • TABLE 5 GLOBAL: SPINAL NEEDLES MARKET, FOR DIRECTIONAL SPINAL NEEDLES, BY REGIONS, 2018-2027 (USD MILLION)
  • TABLE 6 GLOBAL: SPINAL NEEDLES MARKET, FOR PENCIL-POINT NEEDLES, BY REGIONS, 2018-2027 (USD MILLION)
  • TABLE 7 GLOBAL: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 8 GLOBAL: SPINAL NEEDLES MARKET, FOR THERAPEUTIC, BY REGIONS, 2018-2027 (USD MILLION)
  • TABLE 9 GLOBAL: SPINAL NEEDLES MARKET, FOR DIAGNOSTIC, BY REGIONS, 2018-2027 (USD MILLION)
  • TABLE 10 GLOBAL: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 11 GLOBAL: SPINAL NEEDLES MARKET, FOR HOSPITALS & CLINICS, BY REGIONS, 2018-2027 (USD MILLION)
  • TABLE 12 GLOBAL: SPINAL NEEDLES MARKET, FOR DIAGNOSTICS CENTERS, BY REGIONS, 2018-2027 (USD MILLION)
  • TABLE 13 GLOBAL: SPINAL NEEDLES MARKET, FOR RESEARCH LABORTORIES, BY REGIONS, 2018-2027 (USD MILLION)
  • TABLE 14 GLOBAL: SPINAL NEEDLES MARKET, FOR SPECIALITY CENTERS, BY REGIONS, 2018-2027 (USD MILLION)
  • TABLE 15 GLOBAL: SPINAL NEEDLES MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 16 AMERICAS: SPINAL NEEDLES MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 17 AMERICAS: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 18 AMERICAS: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 19 AMERICAS: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 20 NORTH AMERICA: SPINAL NEEDLES MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 21 NORTH AMERICA: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 22 NORTH AMERICA: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 23 NORTH AMERICA: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 24 US: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 25 US: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 26 US: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 27 CANADA: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 28 CANADA: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 29 CANADA: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 30 LATIN AMERICA: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 31 LATIN AMERICA: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 32 LATIN AMERICA: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 33 EUROPE: SPINAL NEEDLES MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 34 EUROPE: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 35 EUROPE: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 36 EUROPE: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 37 WESTERN EUROPE: SPINAL NEEDLES MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 38 WESTERN EUROPE: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 39 WESTERN EUROPE: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 40 WESTERN EUROPE: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 41 GERMANY: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 42 GERMANY: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 43 GERMANY: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 44 FRANCE: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 45 FRANCE: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 46 FRANCE: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 47 UK: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 48 UK: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 49 UK: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 50 ITALY: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 51 ITALY: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 52 ITALY: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 53 SPAIN: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 54 SPAIN: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 55 SPAIN: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 56 REST OF WESTERN EUROPE: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 57 REST OF WESTERN EUROPE: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 58 REST OF WESTERN EUROPE: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 59 EASTERN EUROPE: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 60 EASTERN EUROPE: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 61 EASTERN EUROPE: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 62 ASIA PACIFIC: SPINAL NEEDLES MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 63 ASIA PACIFIC: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 64 ASIA PACIFIC: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 65 ASIA PACIFIC: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 66 CHINA: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 67 CHINA: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 68 CHINA: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 69 INDIA: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 70 INDIA: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 71 INDIA: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 72 JAPAN: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 73 JAPAN: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 74 JAPAN: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 75 SOUTH KOREA: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 76 SOUTH KOREA: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 77 SOUTH KOREA: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 78 AUSTRALIA: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 79 AUSTRALIA: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 80 AUSTRALIA: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 81 REST OF ASIA PACIFIC: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 82 REST OF ASIA PACIFIC: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 83 REST OF ASIA PACIFIC: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 84 MIDDLE EAST & AFRICA: SPINAL NEEDLES MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 85 MIDDLE EAST & AFRICA: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 86 MIDDLE EAST & AFRICA: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 87 MIDDLE EAST & AFRICA: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 88 MIDDLE EAST: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 89 MIDDLE EAST: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 90 MIDDLE EAST: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 91 AFRICA: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 92 AFRICA: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 93 AFRICA: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 94 MAJOR PLAYERS IN THE GLOBAL SPINAL NEEDLES MARKET
  • TABLE 95 MOST ACTIVE PLAYER IN THE GLOBAL SPINAL NEEDLES MARKET
  • TABLE 96 PRODUCT LAUNCH/PRODUCT APPROVAL
  • TABLE 97 MERGER/ACQUISITION
  • TABLE 98 EXPANSION/INVESTMENT
  • TABLE 99 STRYKER CORPORATION: PRODUCTS/SERVICES OFFERED
  • TABLE 100 STRYKER CORPORATION: KEY DEVELOPMENTS
  • TABLE 101 BOSTON SCIENTIFIC CORPORATION: PRODUCTS/SERVICES OFFERED
  • TABLE 102 BOSTON SCIENTIFIC CORPORATION: KEY DEVELOPMENTS
  • TABLE 103 B. BRAUN MELSUNGEN AG: PRODUCTS/SERVICES OFFERED
  • TABLE 104 B. BRAUN MELSUNGEN AG: KEY DEVELOPMENTS
  • TABLE 105 MEDTRONIC PLC: PRODUCTS/SERVICES OFFERED
  • TABLE 106 MEDTRONIC PLC: KEY DEVELOPMENTS
  • TABLE 107 SMITHS MEDICAL: PRODUCTS/SERVICES OFFERED
  • TABLE 108 SMITHS MEDICAL: KEY DEVELOPMENTS
  • TABLE 109 BECTON, DICKINSON, AND COMPANY: PRODUCTS/SERVICES OFFERED
  • TABLE 110 BECTON, DICKINSON, AND COMPANY: KEY DEVELOPMENTS
  • TABLE 111 EXELINT INTERNATIONAL, CO.: PRODUCTS/SERVICES OFFERED
  • TABLE 112 ARGON MEDICAL: PRODUCTS/SERVICES OFFERED
  • TABLE 113 ARGON MEDICAL: KEY DEVELOPMENTS
  • TABLE 114 MYCO MEDICAL: PRODUCTS/SERVICES OFFERED
  • TABLE 115 COOK MEDICAL: PRODUCTS/SERVICES OFFERED
  • TABLE 116 COOK MEDICAL: KEY DEVELOPMENTS

LIST OF FIGURES

  • FIGURE 1 MARKET SYNOPSIS
  • FIGURE 2 GLOBAL SPINAL NEEDLES MARKET
  • FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
  • FIGURE 4 MARKET DYNAMICS: GLOBAL SPINAL NEEDLES MARKET
  • FIGURE 5 DRIVERS: IMPACT ANALYSIS
  • FIGURE 6 RESTRAINTS: IMPACT ANALYSIS
  • FIGURE 7 VALUE CHAIN ANALYSIS OF GLOBAL SPINAL NEEDLES MARKET
  • FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: GLOBAL SPINAL NEEDLES MARKET
  • FIGURE 9 GLOBAL SPINAL NEEDLES MARKET, BY TYPE, 2020 & 2027 (USD MILLION)
  • FIGURE 10 GLOBAL SPINAL NEEDLES MARKET, BY APPLICATION, 2020 & 2027 (USD MILLION)
  • FIGURE 11 GLOBAL SPINAL NEEDLES MARKET, BY END USER, 2020 & 2027 (USD MILLION)
  • FIGURE 12 GLOBAL: SPINAL NEEDLES MARKET, BY REGION 2020 & 2027 (USD MILLION)
  • FIGURE 13 GLOBAL: SPINAL NEEDLES MARKET SHARE (%), BY REGION, 2020
  • FIGURE 14 AMERICAS: SPINAL NEEDLES MARKET SHARE (%), BY REGION 2020
  • FIGURE 15 NORTH AMERICA: SPINAL NEEDLES MARKET SHARE (%), BY COUNTRY 2020
  • FIGURE 16 EUROPE: SPINAL NEEDLES MARKET SHARE (%), BY REGION, 2020
  • FIGURE 17 WESTERN EUROPE: SPINAL NEEDLES MARKET SHARE (%), BY COUNTRY, 2020
  • FIGURE 18 ASIA PACIFIC: SPINAL NEEDLES MARKET SHARE (%), BY COUNTRY 2020
  • FIGURE 19 MIDDLE EAST & AFRICA: SPINAL NEEDLES MARKET SHARE (%), BY REGION, 2020
  • FIGURE 20 BENCHMARKING OF MAJOR COMPETITORS
  • FIGURE 21 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL SPINAL NEEDLES MARKET
  • FIGURE 22 GLOBAL SPINAL NEEDLES MARKET: COMPETITIVE LANDSCAPE
  • FIGURE 23 SALES (USD MILLION) AND OPERATING PROFIT MARGIN (%), 2020
  • FIGURE 24 R&D EXPENDITURE (USD MILLION), 2020
  • FIGURE 25 STRYKER CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 26 STRYKER CORPORATION: SWOT ANALYSIS
  • FIGURE 27 BOSTON SCIENTIFIC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 28 BOSTON SCIENTIFIC CORPORATION: SWOT ANALYSIS
  • FIGURE 29 B. BRAUN MELSUNGEN AG: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 30 B. BRAUN MELSUNGEN AG: SWOT ANALYSIS
  • FIGURE 31 MEDTRONIC PLC: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 32 B MEDTRONIC PLC: SWOT ANALYSIS
  • FIGURE 33 SMITHS GROUP PLC: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 34 SMITHS MEDICAL: SWOT ANALYSIS
  • FIGURE 35 BECTON, DICKINSON, AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 36 BECTON, DICKINSON, AND COMPANY: SWOT ANALYSIS
  • FIGURE 37 EXELINT INTERNATIONAL, CO.: SWOT ANALYSIS
  • FIGURE 38 ARGON MEDICAL: SWOT ANALYSIS
  • FIGURE 39 MYCO MEDICAL: SWOT ANALYSIS
  • FIGURE 40 COOK MEDICAL: SWOT ANALYSIS